WT1 Levels At Diagnosis and POST-Induction Provide Prognostic Information in Adult De Novo AML. Results From the Spanish Cetlam Group
Abstract 2524▪▪This icon denotes a clinically relevant abstract WT1 monitoring is an almost universal target to follow de novo AML. Its exppression in myeloid malignancies is upregulated in parallel to the blast percentage. Recently, WT1 determination has been standardized as result of an European L...
Saved in:
Published in | Blood Vol. 120; no. 21; p. 2524 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
16.11.2012
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!